UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Edgewell Personal Care
EPC
$1.29B
| $3.11M | ﹤0.01% |
73,223
+6,875
| +10% | +$288K |
|
1377
MP Materials
MP
$9.73B
| $3.1M | ﹤0.01% |
+109,995
| New | +$3.33M |
|
1378
FirstCash
FCFS
$9.05B
| $3.1M | ﹤0.01% |
32,510
+1,383
| +4% | +$125K |
|
1379
Progress Software
PRGS
$1.78B
| $3.09M | ﹤0.01% |
53,796
-162
| -0.3% | -$9.03K |
|
1380
Red Rock Resorts
RRR
$3.58B
| $3.09M | ﹤0.01% |
69,292
+2,185
| +3% | +$96.6K |
|
1381
Resideo Technologies
REZI
$3.67B
| $3.08M | ﹤0.01% |
168,707
+29,170
| +21% | +$528K |
|
1382
Noble Corp
NE
$6.95B
| $3.08M | ﹤0.01% |
78,052
-5,800
| -7% | -$232K |
|
1383
Bread Financial
BFH
$4.38B
| $3.08M | ﹤0.01% |
101,441
-774,306
| -88% | -$29M |
|
1384
Minerals Technologies
MTX
$2.32B
| $3.07M | ﹤0.01% |
50,820
+4,996
| +11% | +$311K |
|
1385
MasterBrand
MBC
$1.84B
| $3.06M | ﹤0.01% |
380,901
+158,600
| +71% | +$1.4M |
|
1386
TripAdvisor
TRIP
$1.26B
| $3.06M | ﹤0.01% |
154,174
+12,186
| +9% | +$260K |
|
1387
Fluor
FLR
$7.3B
| $3.05M | ﹤0.01% |
98,532
-26,236
| -21% | -$902K |
|
1388
Kontoor Brands
KTB
$4.27B
| $3.04M | ﹤0.01% |
+62,850
| New | +$2.98M |
|
|
FOCS
1389
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $3.04M | ﹤0.01% |
58,514
-328
| -0.6% | -$15.8K |
|
1390
Commault Systems
CVLT
$5.78B
| $3.03M | ﹤0.01% |
53,320
-103,530
| -66% | -$6.17M |
|
1391
UMB Financial
UMBF
$11.1B
| $3.01M | ﹤0.01% |
52,149
+3,397
| +7% | +$276K |
|
|
FOLD
1392
DELISTED
Amicus Therapeutics
FOLD
| $3.01M | ﹤0.01% |
271,402
+21,731
| +9% | +$268K |
|
1393
Affirm
AFRM
$25.3B
| $3.01M | ﹤0.01% |
266,940
-276,599
| -51% | -$3.48M |
|
1394
Viavi Solutions
VIAV
$9.18B
| $3M | ﹤0.01% |
277,448
+40,516
| +17% | +$441K |
|
1395
Calix
CALX
$2.4B
| $3M | ﹤0.01% |
56,065
+6,019
| +12% | +$328K |
|
1396
Rapid7
RPD
$776M
| $3M | ﹤0.01% |
65,435
+2,051
| +3% | +$87.3K |
|
1397
Independent Bank
INDB
$3.97B
| $3M | ﹤0.01% |
45,722
+8,569
| +23% | +$655K |
|
1398
Community Bank
CBU
$3.37B
| $3M | ﹤0.01% |
57,156
+5,088
| +10% | +$298K |
|
1399
Dycom Industries
DY
$12B
| $2.99M | ﹤0.01% |
31,977
-4,782
| -13% | -$444K |
|
1400
HUB Group
HUBG
$2.9B
| $2.99M | ﹤0.01% |
71,222
+3,334
| +5% | +$145K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.